PHS News

Valdez and UVA Co-PIs awarded RO1 from National Library of Medicine

Dr. Rupa Valdez (Public Health Sciences), Dr. Steve Patek (Systems and Information Engineering), Dr. Mark Deboer (Pediatric Endocrinology), and Dr. Daniel Chernavvsky (Psychiatry and Neurobehavioral Sciences) are PIs on a recently funded R01 from the National Library of Medicine. The purpose of this …

Balkrishnan: Report on U.S. Kidney Disease Care shows major cost, garners major press

A recent report using data from the the U.S. Renal Data System of the care and cost of renal disease shows an enormous and growing health care issue. PHS’s Rajesh Balkrishnan, Ph.D., led the report’s analysis of prescription drug use and cost. Read the full article here. The report has been receivin …

Targonski named Director of Research for Division of GGPC&HM

Dr. Paul Targonski has accepted the new role of Director of Research for the Division of General, Geriatrics, Palliative Care and Hospital Medicine of the University of Virginia Health System. “Paul is a widely experienced clinician researcher who joined UVA Public Health Sciences Department with  j …

Balkrishnan, Cancer Center colleagues featured in Cavalier Daily, UVAToday

Research by the Department’s Rajesh Balkrishnan and colleagues in the Cancer Center has been featured in The Cavalier Daily and UVAToday.

Yan and Colleagues Present at Nephrology Society Annual Meeting

Professor of Public Health Sciences Guofen Yan and colleagues recently presented study findings to further the understanding of minorities’ survival advantage on dialysis at the 2015 American Society of Nephrology Annual Meeting. Across the United States, more than 400,000 kidney failure patients re …

Engelhard writes: We are all on the government dole

Our resident health care policy expert, Carolyn L. Engelhard, writes regularly for The Hill. Read her latest explanation of the intricacies of American health care policy here.

Yan, et al. publish findings shedding light on state-level variations in treatment of kidney disease

More than 600,000 Americans in 2012 were treated for kidney failure (end-stage renal disease or ESRD). A growing body of evidence indicates that many of these patients could have experienced successful interventions if treated at an earlier stage of the disease. In a study appearing in an upcoming i …